Russia's Gamaleya Center Applies For Study Of COVID Vaccine For Children Aged 6-11- Chief

Russia's Gamaleya Center Applies for Study of COVID Vaccine for Children Aged 6-11- Chief

The Gamaleya Research Center for Epidemiology and Microbiology has submitted documents to obtain permission to research a vaccine against coronavirus among children aged six to 11, the director of the center, Alexander Gintsburg, said

BARVIKHA (Pakistan Point News / Sputnik - 29th November, 2021) The Gamaleya Research Center for Epidemiology and Microbiology has submitted documents to obtain permission to research a vaccine against coronavirus among children aged six to 11, the director of the center, Alexander Gintsburg, said.

"We have already submitted documents for children aged 6-11 this morning," Gintsburg told reporters.

This vaccine must be included in the national immunization schedule, he added.